Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thioglycolic Acid Peeling vs IPL for Periorbicular Hyperchromia
NCT03238105Phase 4Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Aug 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Thioglycolic acid in periorbital hyperpigmentation (POH) (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoints: Global Aesthetic Improvement Scale at 5 months and Visual Analogue Scale for Clinical Improvement at 5 months. Status: unknown.
02
Drugs
Thioglycolic acid
03
Conditions
periorbital hyperpigmentation (POH)
Beyond the preview
Go deeper on NCT03238105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238105.